Podcasts about Liver cancer

In this episode of the Onc Now Podcast, host Jonathan Sackier is joined by Stephen Chan, Clinical Professor at the Department of Clinical Oncology of the Chinese University of Hong Kong, to discuss groundbreaking trials in hepatobiliary cancers, the role of diet in chronic liver disease, and the future of liver cancer care.  Timestamps:    00:00 – Introduction  02:09 – CARES-310 trial for liver cancer   4:33 – Camrelizumab + rivoceranib versus sorafenib  7:07 – Prevention and early detection of liver cancer   10:30 – Impact of lifestyle and diet on liver disease  12:38 – KEYNOTE-966 trial for biliary tract cancer  14:45 – Alternative strategies for liver cancer treatment  17:14 – Key initiatives of the International Liver Cancer Association  19:26 – Chan's three wishes for healthcare 

A study published in JAMA Internal Medicine found that statin use in patients with chronic liver disease was associated with a lower risk of liver cancer and hepatic decompensation, suggesting potential protective effects beyond lipid management. Surveys by the Annenberg Public Policy Center revealed widespread misinformation about the risks of consuming raw milk, highlighting the need for public education on the importance of pasteurization. New research links red meat allergy (alpha-gal syndrome) to bites from deer ticks and western black-legged ticks, expanding the geographic risk area and emphasizing the need for clinicians to consider this diagnosis in patients with unexplained allergic symptoms following tick bites.

Big Pharma pays billions for direct-to-consumer TV drug ads—is it time to ban them? Focused ultrasound obliterates liver tumors with minimal side effects; Nurse tricks woman into believing she's dying of cancer to cash in on her $1.5 million life insurance policy; Arizona bans insurance denial by AI automated systems; Study overturns view that very low-carb diets are bad for kidney disease patients; Strategies for reviving a lagging thyroid.

In 2021, Albertina Dancy began to experience abdominal pain, but that wasn't all.  She also had gastrointestinal issues, jaundice and other problems.  However, she didn't take them seriously and thought they could be successfully addressed with over-the-counter remedies.  When that didn't happen, she sought medical attention.   Albertina's doctor said the symptoms, combined with her existing fatty liver disease, merited a trip to an oncologist.  A series of scans and tests, plus the stiffness of her liver, led to a diagnosis of liver cancer.   The diagnosis left Albertina depressed, wondering if she would get well again.  She regrets not seeking medical attention at an earlier time because doctors said her only treatment option with a regimen of radiation treatment and chemotherapy.   The chemo was extremely tough on Albertina.  She was in constant pain, felt extreme fatigue and was demoralized about losing all her hair.   However, she achieved survivorship and says because she pays close attention to diet and exercise, her health is better than it was prior to her diagnosis.   By way of advice, Albertina Dancy strongly advises anyone suffering unusual health issues to immediately seek medical attention.   Additional Resources:   American Liver Foundation: https://www.liverfoundation,org      

Send us a textDr. Chari A. Cohen, DrPH, MPH ( https://blumberginstitute.org/faculty/chari-a-cohen/ ) is the President of the Hepatitis B Foundation ( https://www.hepb.org/ ), a global nonprofit dedicated to finding a cure and improving the quality of life for people affected by hepatitis B worldwide.Dr. Cohen conducts research and implements programs to reduce health disparities and improve health outcomes associated with hepatitis B, as well as hepatitis D, and liver cancer. Dr. Cohen is also co-chair of the Hep B United Coalition, co-founder and chair of Hep B United Philadelphia, co-founder and chair of CHIPO: Coalition Against Hepatitis for People of African Origin; and immediate past co-chair of the Hep Free PA Coalition. Dr. Cohen is also a member of the International Coalition to Eliminate of HBV (ICE-HBV) steering committee, HepVu advisory committee (an online platform that visualizes data and disseminates insights on the viral hepatitis epidemic across the U.S), and HBV Forum for Collaborative Research. Dr. Cohen serves as both a Professor at the Baruch S. Blumberg Institute, and adjunct faculty for Geisinger Commonwealth School of Medicine. Dr. Cohen received her DrPH in Community Health and Prevention from Drexel University and her MPH from Temple University.The Baruch S. Blumberg Institute ( https://blumberginstitute.org/ ) is a nonprofit translational research organization focused on understanding the pathobiology of hepatitis B virus and related diseases, developing diagnostics for early detection of liver cancer, and discovering therapeutics, antivirals and immune modulators for the cure of chronic HBV and other RNA viruses that cause hepatitis and hemorrhagic fever.#ChariCohen #HepatitisBFoundation #HepBVaccine #BaruchSBlumberg #LiverCancer #Cirrhosis #AntiVirals #HarmReduction  #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Join this EASL Studio episode for a clinical perspective on advancing HCC care. Explore the realities of adjuvant therapies, emerging molecular targets, and strategies for curative conversion. Gain insights into practical innovations shaping the future and translating research into improved patient outcomes.Moderator: Thomas BergFaculty: Tim Greten and Anna SaborowskiThis EASL Studio is supported by Bayer.EASL has received no input from Bayer with regards to the content of this programme.Related episodes:EASL Studio S5E13: Basics in decision-making for liver cancer treatmentEASL Studio from EASL Congress 2023: Highlights of the liver cancer research at EASL Congress 2023EASL Studio S4E16: Highlights from the EASL Liver Cancer Summit 2023EASL Studio S6E9: Therapy hierarchy in HCC: A new kid on the blockAll EASL Studio Podcasts are available on EASL Campus.

In this episode, Amy Michelle Wilcockson opens her heart and shares her incredible journey of transformation—from battling thyroid cancer and liver cancer to creating the life of her dreams.Contact Amy  linktr.ee/willcocksonFor years, Amy was known as a Doctor of Chiropractic and the Director of Live Healthy Iowa, dedicated to helping others live healthier lives. But while she was focused on healing others, her own health was falling apart.The Breaking Point✅ At the peak of her career, her personal life was crumbling✅ Her mental and physical health were in crisis✅ She was diagnosed with IBS, food intolerances, hypothyroidism, Hashimoto's, a liver tumor, and thyroid cancer✅ Doctors gave her grim news—she was dying✅ She had to make a choice—keep pushing forward or fight for her lifeThe Turning Point

In this episode, host Courtney Allison discusses the latest studies on the health risks associated with alcohol use with Dr. Robert Brown, chief of Gastroenterology and Hepatology at NewYork-Presbyterian and Weill Cornell Medicine. They discuss how alcohol affects various organs, including your liver, heart, and brain, as well as its link to several cancers. Dr. Brown discusses the cultural perception of alcohol, the current guidelines around safe drinking limits, and how binge drinking harms the body. 

#2024 #CollegeFootball #ColoradoBuffaloes #TravisHunter #HeismanTrophy #RashaanSalaam #ChicagoBears #CrossSports #MichiganFootball #GoBlue #OhioState #Alabama #ReliaQuest #Oregon #Texas #Georgia #RandyMoss #KansasCityChiefs #DetroitLions #MattEberflus #ThomasBrown #BenJohnson #MikeVrabel #JoeBrady #BrianFlores #FinalMessageOf2024 #2025pickup Colorado Buffaloes cornerback/wide receiver, Travis Hunter, won the 2024 Heisman Trophy.Which team will win the College Football National Championship?We also talked about the big game between Michigan & Ohio State. Go Blue!We talked about NFL Hall of Famer, Randy Moss! God WILL heal his body from Liver Cancer!We also, talked about the Chicago Bears's situation and who they should hire as their next head coach and we leave you all with Cross Sports's message to close out 2024 and entering 2025!Frank Jackson, he sales jerseys. Hockey jerseys too! Facebook him!!Ovidio's Big Leap Ink: https://bigleapink.com  Darrick's catering business: https://apeelinggourmet.godaddysites.com Epidemic Sound - Relate Epidemic Sound - Jay TroitEpidemic Sound - DaytonaEpidemic Sound - Sub-ZeroEpidemic Sound - Here NowEpidemic Sound - Rain TrapEpidemic Sound - Jingle Bells (Pop version)Epidemic Sound - FireworksEpidemic Sound - Mass  Instagram - @CrossSports_   Twitter - @crosssportsllc    TikTok - @crosssports77

Dr Daneng Li shares his perspectives on the evolving therapeutic landscape for patients with hepatobiliary cancers, moderated by Dr Stephen "Fred" Divers. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/AON24).

Randy Moss' son LIVID! CURSES OUT Larry Fitzgerald Sr for LEAKING Moss' Liver Cancer diagnosis!

Husker VB awards / Prayers up for Randy Moss battling liver cancer: December 11th, 8:25amAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

On so many issues, Congress has not been willing or able to act. But when faced with horrifying stories of death and mismanagement, Congress finally passed legislation to reform the US organ transplant system. They did so because people like Donna Cryer, a transplant recipient and patient advocate, demanded a better system for Americans who need lifesaving organ transplants. Now, as the new law moves into implementation, the work continues. In this episode, Donna and I discuss:The new legislation that is breaking up the deadly organ transplant monopolyHow ignoring the expertise and insights of patients dooms us to slow progress making healthcare safer and better Her advice for young people: “take your shot”Donna says we all need to start listening more closely to patients with lived experience:“I often think if you... had many people with great deals of experience and intelligence who were highly motivated to help you achieve your goal. Why would you not want to use them? Why would you not want to partner with them? Why would you work really, really hard to keep them away from solving the problem? And that's how people treat patients and patient advocates.”Relevant LinksDonna Cryer's testimony to the Senate Finance Committee on organ transplant system failures (just past the 48:00 mark)Summary of the new law to break up the organ transplantation monopolyMore about the Global Liver InstituteSee more details about the Advanced Advocacy Academy Donna's organization launchedVisit UNOS' websiteAbout Our GuestDonna R. Cryer, JD is the Founder and former Chief Executive Officer of Global Liver Institute, the only patient-driven liver health nonprofit operating across the US, EU, and UK. GLI convenes the NASH, Liver Cancer and Pediatric and Rare Liver Disease Councils, as well as the Liver Action Network, collectively more than 200 organizations.Mrs. Cryer has channeled her personal experience as a patient with inflammatory bowel disease and a 29-year liver transplant recipient into professional advocacy across a career in law, policy, consulting, public relations, clinical trial recruitment, and nonprofit management. At GLI, Mrs. Cryer has raised more than $10 million for liver health initiatives. She is a frequent speaker on the topic of patient-centeredness and patient engagement in healthcare transformation and created a unique model for advocacy that mobilizes patients, influences policy, and coalesces clinicians to improve patient outcomes.Mrs. Cryer serves on the Boards of Directors for the Council of Medical Specialty Societies, Sibley Memorial Hospital/Johns Hopkins Medicine, the Innovation and Value Initiative (IVI), and the Clinical Trials Transformation Initiative. She was the first patient to serve on the ABIM Gastroenterology Specialty Board, was one of the founding members of the AASLD Patient Advisory Committee and is the Community Representative on the AASLD NASH Task Force. She has been named one of the Top Blacks in Healthcare by the Milken Institute at GW School of Public Health and BlackDoctors.org, one of the Top 10 Patients Who Make An Impact by Health 2.0 and one of PharmaVoice's 100 Most...

This episode of Walk, Don't Run to the Doctor emphasizes the importance of building and maintaining a healthy microbiome for better health outcomes, disease prevention, and overall well-being. The microbiome, a complex population of microorganisms living in the gut, plays a significant role in protecting against cancer, regulating digestion, and supporting various metabolic and immune functions. A home-cooked diet, particularly a whole food omnivorous diet rich in fiber and fermented foods, helps to cultivate a resilient microbiome. Exercise, scant to moderate alcohol consumption (especially wine), and avoiding sugar, refined flours, and artificial sweeteners further enhance gut health. This episode also warns against overuse of antibiotics and reliance on probiotic supplements, advocating instead for a food-based approach through diet and lifestyle changes. Key Takeaways: Microbiome's Role in Health: The microbiome impacts everything from cancer prevention to appetite regulation, insulin sensitivity, immune function, and even brain health. Diet and Gut Health: A Mediterranean-style, omnivorous whole food, diet improves microbiome diversity and overall health, reducing risks for conditions like obesity, diabetes, and cancer. Fermented Foods: Incorporating fermented foods like yogurt, kefir, and kombucha supports a healthy microbiome and reduces cancer risk. Exercise and Lifestyle: Regular exercise promotes gut health and boosts immunity, while avoiding sugar, artificial sweeteners, and unnecessary antibiotics helps maintain microbiome balance. Natural Approach: The podcast recommends focusing on diet and lifestyle over probiotic or prebiotic supplements to build a resilient microbiome. For more insights and advice on reducing dependence on medications through lifestyle changes, make sure to subscribe to Walk, Don't Run to the Doctor. More references can be found at www.GreatMed.org Would you like Dr. Hassell to answer your question on the air?  Contact us! Phone/text: 503-773-0770 e-mail: info@GreatMed.org Write us a letter.  We love to hear from you.  This podcast is sponsored by our generous listeners.  Send questions, comments, and support to: 4804 NW Bethany Blvd., Suite I-2, #273 Portland OR 97229 References:           Zhang, X., et al. (2023). Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights form the BE GONE trial. The Lancet, 98:104873. https://doi.org/10.1016/j.ebiom.2023.104873            Diez-Ozaeta, I. & Astiazaran, O. (2021). Fermented foods: An update on evidence-based health benefits and future perspectives. Food Research International, 156. https://doi.org/10.1016/j.foodres.2022.111133            Perler, B., et al. (2023). The role of the gut microbiota in the relationship between diet and human health. Annual Reviews in Physiology, 85:449-68. https://doi.org/10.1146/annurev-physiol-031522-092054            DeVos, W., et al. (2022). Gut microbiome and health: mechanistic insights. Gut-BMJ, 71:1020-1032. doi: 10.1136/gutjnl-2021-326789            Kim, J., and Le, H. (2022). Potential role of the gut microbiome in colorectal cancer progression.  Frontiers in Immunology, 12: 807648. doi: 10.3389/immu.2021.807648            Pyo, Y., et al. (2024). Probiotic functions in fermented foods: Anti-viral, Immunomodulatory, and anti-cancer benefits. Foods, 13:2386. https://doi.org/10.3390/foods13152386            Zhang, K., et al. (2019) Fermented dairy foods intake and risk of  cancer. International Journal of Cancer, 144: 2099-2108.            Michels, K. B., et al. (2020). Yogurt consumption and colorectal cancer incidence and mortality in the Nurses' Health Study and the Health Professionals Follow-Up Study. The American journal of clinical nutrition, 112(6), 1566–1575. https://doi.org/10.1093/ajcn/nqaa244            Shams-White, M., et al. (2022). The 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Score and All-Cause, Cancer, and Cardiovascular Disease Mortality Risk: A Longitudinal Analysis in the NIH-AARP Diet and Health Study, Current Developments in Nutrition, Volume 6, Issue 6, nzac096,ISSN 2475-2991,https://doi.org/10.1093/cdn/nzac096.            Rad, A., et al. (2021). Postbiotics as promising tools for cancer adjuvant therapy. Advanced Pharmaceutical Bulletin, 11(1), 1-5. https://apb.tbzmed.ac.ir            Sharma, A., et al. Final results of a phase I/II study to investigate efficacy of a high potency multistrain probiotic on chemo induced diarrhea. ESMO, 29(8). Doi:10.1093/annonc/mdy424            Luceron-lucas-Torres, M., et al. Association between wine consumption and cancer: a systematic review and meta-analysis. Frontiers in Nutriition, 10:1197745. doi: 10.3389/fnut.2023.1197745            LeRoy, C., et al. (2020). Red  Wine Consumption  Associated with increased gut microbiota a-diversity in 3 independent cohorts. Gastroenterology, 158:270-272. https://doi.org/10.1053/j.gastro.2019.024            Duan, J., et al. (2021). The mechanisms of wine phenolic compounds for preclinical anticancer therapies. Food and Nutrition Research, 65:6507. http://dx.doi.org/10.29219/fnr:v65.6507            Zhao, L., et al. (2023). Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Liver Cancer and Chronic Liver Disease Mortality. JAMA, 330(6), 537–546. https://doi.org/10.1001/jama.2023.12618            Debras, C., et al. (2022). Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study. PLoS medicine, 19(3), e1003950. https://doi.org/10.1371/journal.pmed.1003950            Zhang, J., et al. (2019). Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989-2012: a matched case-control study. Gut.BMJ; 68:1971-1978. doi: 10.1136/gutnl-2019-318593

Your liver's biggest role is to remove toxins from your blood, but what happens when that function is impaired by cancer? Consultant general and hepatobiliary surgeon Dr Balraj Singh from Pantai Hospital Kuala Lumpur joins us to share more about liver cancer and how it impacts liver function. He'll also be talking about early detection of liver cancer and advances in treatment.

Liver cancer or hepatocellular cancer is the 6th most common cause of cancer and the 3rd leading cause of cancer deaths worldwide. In the US, liver cancer is the 6th leading cause of death. Common risk factors of liver cancer:•Cirrhosis or liver scarring and it's underlying risk factors (20% of cases of liver cancer form without cirrhosis present, yet in the presence of or more of the below conditions) •Metabolic Dysfunction-Associated Steatotic Liver Disease (formerly, non-alcoholic fatty liver disease) of which obesity, diabetes and high cholesterol are risk factors •Hepatitis B and Hepatitis C (transmitted via body fluids, commonly during sex, childbirth (mother to fetus) or with IV drug use) •Alcohol •Smoking •Aflatoxin (a fungus that may grow on grains and nuts improperly store in hot and humid environments) Common symptoms of liver cancer:•None•Abdominal discomfort•Abdominal swelling •Nausea or vomiting•Gastrointestinal bleeding•Weight loss•Loss of appetite •Jaundice (yellowing of the skin and whites of the eyes)•Easy bruising or bleeding•Persistent itching•Fatigue•Fever Populations at increased risk for liver cancer:Nationally, the highest rates are seen in Asian/Pacific Islanders and American Indian/Alaskan Natives. Rising rates have been noted in the Latinx population. Globally, rates are actually highest outside the US, in sub-Saharan Africa and Southeast Asia. Liver cancer prevention:•Eat whole food, plant-forward nutrition (fruits, vegetables, lean proteins, whole grains, minimal saturated fat)•Reduce alcohol intake or abstain https://www.cdc.gov/alcohol/about-alcohol-use/index.html •Get screened for and vaccinated against hepatitis B (infants, children and adults) https://www.cdc.gov/hepatitis-b/index.html*Get screened and treated for hepatitis C (no vaccine currently exists and many patients are without symptoms, which often only occur with advanced disease.) https://www.cdc.gov/hepatitis-c/index.html •Practice safer sex with regular condom use (including same gender couples)•Get screened for STDs annually or with every new partnerSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Anousha invited Mohamed Ali, a public health professional with the Seattle King County Health Department as well as a board member with Somali Health Board. Mohamed shared his experience working on the liver cancer disparities project and educating Somali communities in Seattle about the link between hepatitis B and liver cancer. Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

Dr. Valentin, radiologist, discusses liver cancer and how the therapy of the TheraSphere Y-90 Glass Microspheres works to help treat cancer in the liver. He will cover how your liver functions, types of liver cancer and the latest treatment options for liver cancer.

Join Laura M. Kulik, MD, a gastroenterologist at Northwestern Medicine, as she explores the latest advances in liver cancer care. Dr. Kulik shares her expertise on emerging therapies and the role of collaborative management in this complex field.

Dr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Robin K (Katie) Kelley from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, summarize the treatment landscape for patients with biliary tract cancers and review recent advancements in the field, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/BTCThinkTank2024).

This recording features audio versions of September 2024 Journal of Vascular and Interventional Radiology (JVIR) abstracts:Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy ReadImage-Guided Energy Ablation for Palliation of Painful Bony Metastases—A Systematic Review ReadImpact of Percutaneous Cryoablation on Renal Function in Patients with Stage I Renal Cell Carcinoma: A Systematic Review and Meta-Analysis ReadPredictive Factors for Recurrent Hemoptysis after Bronchial Artery Embolization in Patients with Lung Cancer ReadRadiofrequency Ablation in Patients with Interstitial Lung Disease and Lung Neoplasm: A Retrospective Multicenter Study ReadEffectiveness of Genicular Artery Embolization for Reducing Synovitis as Assessed by Contrast-Enhanced MR Imaging in Knee Osteoarthritis: A Pilot Study ReadHepatobiliary Infection after Transjugular Intrahepatic Portosystemic Shunt Creation in Patients with Prior Biliary Intervention: A Multi-Institution Retrospective Study ReadJVIR and SIR thank all those who helped record this episode:Host:Manbir Singh Sandhu, University of California Riverside School of MedicineAudio editor:Sonya Choe, University of California Riverside School of MedicineAbstract readers:Maximillian Hayama, Duke University School of MedicineIsabelle Barbosa, Frank H. Netter MD School of MedicineDaniel Roh, Loma Linda University School of MedicineSiddak Dhaliwal, University of Missouri School of MedicineEric Chang, University of Illinois-Chicago College of MedicineJoy Achuonjei, MD, Northwell HealthMaximillian Denys, University of California Riverside School of MedicineSupport the Show.

Multidisciplinary Liver Cancer Care with guest Tamar Taddei July 28, 2024

- Overview of Liver Cancer, Including Current Standard of Care - New Treatment Approaches - Clinical Trial Updates: How Research Increases Your Treatment Options - The Role of Radioembolization - Controlling Symptoms, Treatment Side Effects, Discomfort & Pain - Nutrition & Hydration Concerns & Tips - Communicating with Your Health Care Team about Your Financial Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments, Quality-of-Life Concerns & Discussion of OpenNotes - Questions for Our Panel of Experts

- Overview of Liver Cancer, Including Current Standard of Care - New Treatment Approaches - Clinical Trial Updates: How Research Increases Your Treatment Options - The Role of Radioembolization - Controlling Symptoms, Treatment Side Effects, Discomfort & Pain - Nutrition & Hydration Concerns & Tips - Communicating with Your Health Care Team about Your Financial Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments, Quality-of-Life Concerns & Discussion of OpenNotes - Questions for Our Panel of Experts

This playlist features interviews recorded live by Oncology Data Advisor at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting in Chicago. Visit oncdata.com to learn more!

Join us for a discussion on the critical intersection of diabetes and liver disease. Our guest, Sarah Bauer, a pediatrician, shares her personal journey and insights into the recent screening guidelines released by the American Diabetes Association. From the importance of early detection to bridging the gap between research and practice, we explore actionable steps for improved patient care and advocacy. Sarah Bauer is a pediatrician. She discusses the KevinMD article, "Diabetes and liver disease: urgent screening needs highlighted by personal tragedy." Our presenting sponsor is Nuance, a Microsoft company. Do you spend more time on administrative tasks like clinical documentation than you do with patients? You're not alone. Clinicians report spending up to two hours on administrative tasks for each hour of care provided. Nuance, a Microsoft company, is committed to helping clinicians restore the balance with Dragon Ambient eXperience – or DAX for short. DAX is an AI-powered, voice-enabled solution that helps physicians cut documentation time in half. DAX Copilot combines proven conversational and ambient AI with the most advanced generative AI in a mobile application that integrates directly with your existing workflows. DAX Copilot can be easily enabled within the workflow of the Dragon Medical application to bring the power of ambient technology to more clinicians faster while leveraging the proven and powerful capabilities used by over 550,000 physicians. Explore DAX Copilot today. Visit https://nuance.com/daxinaction to see a 12-minute DAX Copilot demo. Discover clinical documentation that writes itself and reclaim your work-life balance. VISIT SPONSOR → https://nuance.com/daxinaction SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended GET CME FOR THIS EPISODE → https://earnc.me/uhdcvq Powered by CMEfy.

New Guidelines in the Management of Liver Cancer with guest Tamar Taddei April 28, 2024

Brendan Hooley and Dr. Marc Horton, executive medical director of surgical services, surgical chair, and attending surgeon at Providence Swedish Surgical Specialists, discuss an exciting and groundbreaking procedure in the field of liver cancer treatment, called histotripsy. We cover what this treatment is, how it compares to more traditional liver cancer treatments and the impact it may have on cancer treatments in the future. You don't want to miss this fascinating conversation.For more information and resources visit or call:Liver Cancer | Swedish – Find information on histotripsy treatment at the bottom of the page at this link.Providence Swedish makes history with histotripsy – Swedish blog articleCall 206-386-6959 for more information on histotripsy treatment. 

Super Tuesday is underway throughout the country The U.S. Supreme Court temporarily blocked a Texas law on Monday that gives Texas law enforcement officers the ability to arrest illegal aliens entering the country from Mexico. Liver Cancer in Teens, Reduced Sexual Function, Lack of Consent: Internal Docs Reveal Experimental Nature of ‘Gender-Affirming Care': https://www.dailysignal.com/2024/03/05/liver-cancer-teens-reduced-sexual-function-lack-consent-internal-docs-reveal-experimental-nature-gender-affirming-care/ REPORT: […]

Super Tuesday is underway throughout the countryThe U.S. Supreme Court temporarily blocked a Texas law on Monday that gives Texas law enforcement officers the ability to arrest illegal aliens entering the country from Mexico. Liver Cancer in Teens, Reduced Sexual Function, Lack of Consent: Internal Docs Reveal Experimental Nature of ‘Gender-Affirming Care': https://www.dailysignal.com/2024/03/05/liver-cancer-teens-reduced-sexual-function-lack-consent-internal-docs-reveal-experimental-nature-gender-affirming-care/REPORT: Teachers Unions Quietly Spend Millions on GOP Primaries in 32 States: https://www.dailysignal.com/2024/03/04/report-teachers-unions-spend-millions-gop-primaries/On Monday, Arizona Democratic Gov. Katie Hobbs vetoed what she labeled “anti-immigrant legislation.”Independent Arizona Sen. Kyrsten Sinema announced she will not seek re-election Listen to other podcasts from The Daily Signal: https://www.dailysignal.com/podcasts/Get daily conservative news you can trust from our Morning Bell newsletter: DailySignal.com/morningbellsubscription Listen to more Heritage podcasts: https://www.heritage.org/podcastsSign up for The Agenda newsletter — the lowdown on top issues conservatives need to know about each week: https://www.heritage.org/agenda Hosted on Acast. See acast.com/privacy for more information.

We sit down with health care executive Eugene Chan to explore the rising rates of liver cancer worldwide and the potential game-changer in its treatment: monoclonal antibodies. Join us as we delve into the factors contributing to liver cancer's prevalence, the impact of vaccination, and the promising future of mAbs as a more precise and effective treatment approach. Discover the latest research on bi-specific antibodies and the ongoing efforts to improve outcomes for patients battling hepatocellular carcinoma (HCC). Eugene Chan is a health care executive. He discusses the KevinMD article, "Diversified treatments are needed to fight the increasing threat of liver cancer." Our presenting sponsor is Nuance, a Microsoft company. Together, Microsoft and Nuance are leveraging their rich digital technology and advanced AI capabilities to tackle some of health care's biggest challenges. AI-driven technology promises to revolutionize patient and provider experiences with clinical documentation that writes itself. The Nuance Dragon Ambient eXperience, or DAX for short, is a voice-enabled solution that automatically captures patient encounters securely and accurately at the point of care. DAX Copilot combines proven conversational and ambient AI with the most advanced generative AI in a mobile application that integrates directly with your existing workflows. Physicians who use DAX have reported a 50 percent decrease in documentation time and a 70 percent reduction in feelings of burnout, and 85 percent of patients say their physician is more personable and conversational. Discover AI-powered clinical documentation that writes itself. Visit https://nuance.com/daxinaction to see a 12-minute DAX Copilot demo. VISIT SPONSOR → https://nuance.com/daxinaction SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended GET CME FOR THIS EPISODE → https://earnc.me/FT8GkE Powered by CMEfy. 

Erin is a speaker, best-selling author, and licensed massage therapist. In 2009, she was appointed sole Caregiver to her husband as he was diagnosed with cancer, underwent multiple surgeries, and had a successful liver transplant. With caregiving experience that spans over a decade in multiple states with multiple medical centers, Erin was called to share her stories with the underserved caregiving community. Erin is a UNOS Ambassador helping to spread the word about the importance of organ donation. She loves writing, the ocean, snuggling her kitty, and learning new ways to express her creativity.✨Highlights from the show:[00:10:09] Lack of support for caregivers.[00:16:08] Adult coloring books and self-care.[00:20:43] The importance of discussing sex.[00:25:30] Organ donation misconceptions.[00:31:09] The trauma of caregiving.[00:35:07] Your body lets you know.

Hello! There won't be a new episode of Navigating Cancer TOGETHER this week. I am a one-woman show and need to prioritize some goals. However, I do have a teaser for you!The special guest for next week's episode is Erin Copelan. Erin is a caregiver who supported her husband through his cancer journey. She discusses the challenges of being a caregiver and navigating the healthcare system. Erin also shares insights from her book, "Welcome to Caregiving, The Things Caregivers Never Talk About." Tune in on Wednesday, January 31st, to learn more about Erin's experience and the importance of softening the caregiver journey.Until then, listen to episodes where I talk with caregivers from all walks of life who share their experiences, lessons learned, as well as the joys of caregiving.Other Episodes You'll Enjoy:A Woman's Guest to Help Her Husband Overcome Stage 4 Cancer https://smartlink.ausha.co/navigatingcancertogether/a-woman-s-quest-to-help-her-husband-overcome-stage-4-cancer-with-edna-nessMy Sister's Keeper Raising and Losing A Sister to Liver Cancer https://smartlink.ausha.co/navigatingcancertogether/my-sister-s-keeper-raising-and-losing-a-sister-to-liver-cancer-with-andrea-wilson-woodsThe Inspirational Caregiver https://smartlink.ausha.co/navigatingcancertogether/the-inspirational-caregiver-with-dr-odell-glenn-jrHow to Be A Caregiver With No Regrets https://smartlink.ausha.co/navigatingcancertogether/how-to-be-a-caregiver-with-no-regrets-with-rayna-neisesThe Caregiver's Path to Soul Care and Self-Healing https://smartlink.ausha.co/navigatingcancertogether/the-caregivers-path-to-soul-care-and-self-healing-with-dr-edward-smink

In this episode, Bright and Anousha invited Dr. Neehar Parikh, a hepatologist at the University of Michigan to discuss the relationship between hepatitis B and liver cancer, disparities in liver cancer rates, and barriers to liver cancer screening in the United States and globally. Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

When he went to the doctor one year ago he was diagnosed with stage 4 liver cancer along with cirrhosis of the liver. His cancer markers were astronomically high. If he did nothing, doctors told Bert Philippot of British Columbia, Canada that he had 6 months to a year to live. He began taking cannabis oil in February of this year and near the end of March his tumor markers were normal and he is thriving. This is a story to inspire anyone interested in healing.

Dr Lipika Goyal from The Stanford Cancer Center and Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston discuss targeted and immunotherapeutic approaches for biliary tract cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://researchtopractice.com/InsideTheIssue2023/BTC).

You're heading home after work and pull into a drive-thru, ordering a crisp, sweet…

You're heading home after work and pull into a drive-thru, ordering a crisp, sweet…

In this episode, Anousha invited Beatrice Zovich, program manager at the Hepatitis B Foundation along with Rensely and Kenson, who are members of the Micronesian community and reside in Hawaii. As part of the Liver Cancer Disparities Project, Rensely and Kenson shared details about their experience with participating in the focus group discussions of the project.Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

October is Liver Cancer Awareness Month. Dr. Kevin Shih from WellMed at McDermott in San Antonio explains the signs and symptoms to pay attention to, and why liver cancer isn't always a fatal diagnosis. Tune in to this week's episode of Docs in a Pod with co-hosts Ron Aaron and Desarea Murray, NP from WellMed Town Center. Listen to the podcast by searching for Docs in a Pod on Apple Podcasts, Google Podcasts, Pandora, Podbean and Stitcher. Docs in a Pod focuses on health issues affecting adults. Clinicians and partners discuss stories, topics and tips to help you live healthier. Docs in a Pod airs on Saturdays in the following cities: 7 to 7:30 a.m. CT: San Antonio (930 AM The Answer) DFW (660 AM, 92.9 FM [Dallas], 95.5 FM [Arlington], 99.9 FM [Fort Worth]) 6:30 to 7 p.m. CT: Houston (1070 AM/103.3 FM The Answer) 7 to 7:30 p.m. CT: Austin (KLBJ 590 AM/99.7 FM) Docs in a Pod also airs on Sundays in the following cities. 1:30 to 2 p.m. ET: Tampa (860 AM/93.7FM)

10 - 10 - 2023 - Nadine Abi - Jaoudeh MD - October Is Liver Cancer Awareness Month by Tommy G

In December of 2022 10 year old Ramie Darling Jr. was diagnosed with the Pediatric Liver Cancer Hepatoblastoma. HIs father Ramie will talk about his son's diagnosis which occurred in a hospital near their Florida home, but subsequently both father and son moved up to Boston where for the past 8 months  Ramie Jr. has undergone a very successful treatment protocol under the direction of Dr. Allison O'Neill at Boston Children's Hospital.Ramie will talk about his treatment and how well the Darling family, which includes his wife Katie and their 13 and 15 year old daughters, has been treated. Ramie Jr. has spent time at Patriots Training Camp with Quarterback Mac Jones and at Fenway Park with pitcher Garret Whitlock.

According to the Centers for Disease Control, 63 percent of adults aged 18 or older drink sugar-sweetened beverages daily. It is widely known that drinking soda, or pop, can cause you to put on some extra pounds.   But a recent study also linked these types of sweetened drinks to liver cancer.   Let's go through the details of this study and have a look: How bad can soda really be?   ⭕️ Watch in-depth videos based on Truth & Tradition at Epoch TV

Welcome to Episode #035 of Mission Of Spe Podcast. In this episode. Mark will be interviewing Michael Aitken.Mike is an ambitious, disciplined, creative thinker with over 12 years of experience in fundraising, sales, marketing and a Masters in Non-Profit Administration. He founded the Team Runner Racing Team and Foundation to carry on the legacy of my son Runner, who passed away in January of 2015 after a short but courageous battle with Liver Cancer.Team Runner hosts numerous fundraising events annually providing support for local organizations while proudly donning the "Super Runner" Logo as they race and train on the streets of St. Louis and the Midwest Region. In today's episode, you will hear about such topics as: Growing up in sports but no interest in running as a child Competing in race walking in college Make a Wish for his son Runner and his passing Birthday Bash Run for Runner's Birthday Reach out to Mike Aitken: Race Registration: https://runsignup.com/Race/MO/SaintAnn/RunnersBooBash5kandFunRunWalk Instagram:www.instagram.com/teamrunnerracing/ Facebook:https://www.facebook.com/teamrunnerracing

Dr Ghassan Abou-Alfa from Memorial Sloan Kettering Cancer Center in New York and Dr Daneng Li from City of Hope Comprehensive Cancer Center in Duarte, California, discuss the implications of recent data sets for the management of hepatocellular carcinoma moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://researchtopractice.com/PostESMOGI23/HCC)